A comprehensive view of Genetic Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

PacBio announces PureTarget panel to thoroughly examine 20 genes linked to severe neurological conditions; panel offers streamlined methodology for quicker processing of thousands of samples worldwide and will be available from March 25
Published: March 13, 2024 by Zack's Commentary
Bristol-Myers Squibb Champions Genetic Heart Disease Awareness and Clinical Trial Advancement Across Global Divisions
Published: March 07, 2024 by Industry Intelligence Inc.
Biogen's QALSODY, a treatment for the rare genetic form of ALS known as SOD1-ALS, receives a positive recommendation from CHMP; if approved, QALSODY would become the first treatment to target a genetic cause of ALS in the EU
Published: February 23, 2024 by GlobeNewswire Europe
Pierre Fabre Laboratories marks Rare Disease Day on Feb. 29; it highlights its partnerships and innovative treatments for rare genetic diseases in children, such as its work with EspeRare Foundation to treat XLHED, Atara Biotherapeutics for EBV+ PTLD
Published: February 23, 2024 by PR Newswire
Biden-Harris Administration announces sickle cell disease as first focus of the Cell and Gene Therapy (CGT) Access Model, which aims to increase access to therapies and improve health outcomes
Published: January 30, 2024 by U.S. Dept. of Health and Human Services (HHS)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count